Experientia

, Volume 27, Issue 2, pp 168–169 | Cite as

l-DOPA administration to neonate chicks: Effects on behavior and levels of brain biogenic amines

  • J. P. Hanig
  • J. Seifter
Specialia Pharmacologica

Keywords

Evans Blue Hyperlipidic Diet Brain Biogenic Amine 

Zusammenfassung

Nachweis, dass bei Küken die i.v. Injektion vonl-Dopa (100 mg/kg) eine sofortige Überaktivität herbeiführt. Nach 10 min wurde im Gehirn eine Verminderung des Serotoningehaltes (14%) und eine Erhöhung des Dopamingehaltes (12fach) festgestellt, während Adrenalin, Noradrenalin und Histamin unverändert blieben.

References

  1. 1.
    J. P. Hanig andJ. Seifter, Fedn Proc.27, 651 (1968).Google Scholar
  2. 2.
    J. P. Hanig, Doctors Dissertation, New York Medical College, May, 1968.Google Scholar
  3. 3.
    J. P. Hanig, Dissertation Abstracts International, 31, 2162 (1970).Google Scholar
  4. 4.
    N. Clymer andJ. Seifter, J. Pharmac. exp. Ther.89, 149 (1947).Google Scholar
  5. 5.
    H. Waelsch,Biochemistry of the Development of the Nerous System (Academic Press, New York 1955), p. 187.Google Scholar
  6. 6.
    A. Lajtha, J. Neurochem.1, 216 (1957).CrossRefPubMedGoogle Scholar
  7. 7.
    B. J. Key andE. Marley, Electroenceph. clin. Neurophysiol.14, 90 (1962).CrossRefPubMedGoogle Scholar
  8. 8.
    J. P. Hanig, E. Aiello andJ. Seifter, Fedn Proc.25, 452 (1966).Google Scholar
  9. 9.
    C. E. Spooner, Proc. west Pharmac. Soc.11, 98 (1968).Google Scholar
  10. 10.
    J. P. Hanig, E. Aiello andJ. Seifter, Europ. J. Pharmac.12, 180 (1970).CrossRefGoogle Scholar
  11. 11.
    C. C. Chang, Int. J. Neuropharmac.3, 643 (1964).CrossRefGoogle Scholar
  12. 12.
    S. H. Snyder, J. Axelrod andM. Zweig, Biochem. Pharmac.14, 831 (1965).CrossRefGoogle Scholar
  13. 13.
    P. A. Shore, A. Burkhalter andV. H. Cohn jr., J. Pharmac. exp. Ther.127, 182 (1959).Google Scholar
  14. 14.
    G. M. Everett andJ. W. Borcherding, Science168, 849 (1970).CrossRefPubMedGoogle Scholar
  15. 15.
    M. Jouvet, Physiol. Rev.47, 117 (1967).PubMedGoogle Scholar
  16. 16.
    M. Jouvet, inPsychopharmacology; A Review of Progress 1957–1967 (Ed.D. Efron, PHS No. 1836, Washington, D.C. 1968), p. 523.Google Scholar
  17. 17.
    B. J. Koe andA. J. Weissman, J. Pharmac. exp. Ther.154, 499 (1966).Google Scholar
  18. 18.
    M. Mouret, P. Bobillier andM. Jouvet, Europ. J. Pharmac.5, 17 (1968).CrossRefGoogle Scholar
  19. 19.
    O. Hornykiewicz, inBiochemical and Neurophysiological Correlation of Centrally Acting Drugs (Eds.E. Trabucchi, R. Paoletti andN. Canal; Pergamon Press, New York 1964), p. 57.CrossRefGoogle Scholar
  20. 20.
    A. Bertler, inBiochemical and Neurophysiological Correlation of Centrally Acting Drugs (Ed.E. Trabucchi, R. Paoletti andN. Canal; Pergamon Press, New York 1964), p. 51.CrossRefGoogle Scholar
  21. 21.
    T. Sourkes, inBiochemical and Neurophysiological Correlation of Centrally Acting Drugs (Eds.E. Trabucchi, R. Paoletti andN. Canal; Pergamon Press, New York 1964), p. 35.CrossRefGoogle Scholar
  22. 22.
    O. Hornykiewicz, Pharmac. Rev.18, 925 (1966).Google Scholar

Copyright information

© Birkhäuser Verlag 1971

Authors and Affiliations

  • J. P. Hanig
    • 1
  • J. Seifter
    • 1
  1. 1.Department of PharmacologyNew York Medical College, Flower-Fifth Avenue HospitalsNew YorkUSA

Personalised recommendations